Australia's TGA Urges Added Caution For Pediatric Singulair Asthma Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's Therapeutic Goods Administration is calling for added physician caution when prescribing Merck's Singulair (montelukast) for pediatric asthma, saying it has been linked to suicidal thoughts in children and teenagers.